Boryung Pharmaceutical Yesan Campus Begins Operation... First Production of 'Stoga'
[Asia Economy Reporter Cho Hyun-ui] Boryung Pharmaceutical announced on the 20th that its Yesan Campus has officially started operations, beginning with the production of small-pack (30 tablets) Stoga, a treatment for gastritis and gastric ulcers.
Completed in April last year, Boryung Pharmaceutical's Yesan Campus is three times larger than the existing Ansan plant and can be expanded up to five times its current size. For Stoga, the production volume per batch has increased by approximately 2.5 times to about 5 million tablets, and the packaging speed for small packs has become about five times faster.
Boryung Pharmaceutical plans to obtain production approval for 31 solid oral dosage items this year and produce 85% of its total output at the Yesan Campus.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Kakao Partners with Google DeepMind for AI Transparency... "Kanana Watermarking Technology Applied"
- "Groups of 5 or More Now Restricted"... Unrelenting Running Craze Leaves Citizens and Police Exhausted
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Lee Sam-su, President of Boryung Pharmaceutical, stated, “The Yesan Campus is a state-of-the-art smart factory that can efficiently adjust and operate production volumes as needed,” adding, “Although there is currently no shortage in the distribution volume of small-pack Stoga, we will increase the distribution volume of small packs in response to market demand.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
